Home
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
ASCOcancer
20 เม.ย. 2023
การดู 2,927 ครั้ง
Triplet Therapy for Metastatic Hormone-sensitive Prostate Cancer
How does CAR T cell therapy work?
Consolidation Durvalumab Could Be New SOC in Limited-Stage SCLC
Neoadjuvant Nivolumab + Ipilimumab Could Be New SOC in Stage III Melanoma
Nivo+Gem/Cis Is Durable, Improves Survival in Patients With Lymph Node–Only mUC
Adagrasib Improves PFS in Patients With KRASG12C-Mutated NSCLC
Amivantamab + Lazertinib Administration Method May Affect Outcomes in Advanced NSCLC
Telehealth Equally Effective as In-Person Palliative Care in Maintaining QOL in Advanced Lung Cancer
Dr Mats Ljungman KLIPP Targeting Cancer with CRISPR
Osimertinib Improves PFS in EGFR-Mutant, Unresectable, Stage III NSCLC
CROSS Inferior to FLOT in Patients With Esophageal Adenocarcinoma
First-Line Nivolumab/Ipilimumab Improves Survival in Unresectable Hepatocellular Carcinoma
Save the Date for #ASCOBT24 August 8-10, 2024, in Yokohama, Japan
Hear From Past Attendees on Why You Can't Miss #ASCOBT24
Dr. Melvin Chua Invites You to Register for #ASCOBT24
#ASCOBT24: Bringing International Colleagues to the APAC Region
What Makes #ASCOQTLY24 a Must-Attend Meeting
Masterclass 2024 | Supportive care for myeloma and AL amyloidosis patients (Surabhi Chaturvedi)
Global Volunteer Month 2024
Why You Should Submit to #ASCOBT24 With Dr. Van Leyfman